Pliant Therapeutics, Inc. (PLRX) financial statements and ratios from SEC XBRL: revenue $0.00 (TTM), revenue growth -100.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $0.00 |
| Revenue Growth (YoY) | -100.0% |
| EPS Growth (YoY) | 26.2% |
| FCF Growth (YoY) | 35.9% |
| Price / Book | 0.49 |
| FCF Yield | -253.6% |
| Altman Z-Score | -5.70 (distress) |
| Sector P/E (Healthcare) | 21.7 |
PLRX overview · PLRX earnings · PLRX KPIs · PLRX investor relations · PLRX ownership · PLRX peers · PLRX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.